This topic contains a solution. Click here to go to the answer

Author Question: Which of the following best describes the type of medical office practice in which providers network ... (Read 63 times)

Diane

  • Hero Member
  • *****
  • Posts: 576
Which of the following best describes the type of medical office practice in which providers network to offer discounts to employers and other purchasers of health insurance?
 a. Solo proprietorship
  b. Preferred provider organization
  c. Health maintenance organization
  d. Independent practice association

Question 2

A remedy provided by a court decision preventing or requiring someone to perform a particular action defines:
 a. an express contract.
  b. consideration.
  c. an offer.
  d. an injunctive relief.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cam1229

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

b

Answer to Question 2

d




Diane

  • Member
  • Posts: 576
Reply 2 on: Jun 25, 2018
Excellent


brbarasa

  • Member
  • Posts: 308
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Though methadone is often used to treat dependency on other opioids, the drug itself can be abused. Crushing or snorting methadone can achieve the opiate "rush" desired by addicts. Improper use such as these can lead to a dangerous dependency on methadone. This drug now accounts for nearly one-third of opioid-related deaths.

Did you know?

Everyone has one nostril that is larger than the other.

Did you know?

According to animal studies, the typical American diet is damaging to the liver and may result in allergies, low energy, digestive problems, and a lack of ability to detoxify harmful substances.

Did you know?

Never take aspirin without food because it is likely to irritate your stomach. Never give aspirin to children under age 12. Overdoses of aspirin have the potential to cause deafness.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library